PT Cipta Sarana Medika Tbk (IDX:DKHH)
101.00
+1.00 (1.00%)
At close: Nov 5, 2026
IDX:DKHH Revenue
PT Cipta Sarana Medika Tbk had revenue of 39.47B IDR in the quarter ending June 30, 2026, a decrease of -20.57%. This brings the company's total for the last twelve months to 136.01B, down -16.37% year-over-year. In the year 2025, PT Cipta Sarana Medika Tbk had annual revenue of 144.87B, down -4.78%. That makes PT Cipta Sarana Medika Tbk the 38,157th largest company in the world by revenue and 696th in Indonesia.
Revenue (ttm)
136.01B
Revenue Growth
-16.37%
P/S Ratio
1.69
Revenue / Employee
n/a
Employees
578
Market Cap
257.56B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 144.87B | -7.27B | -4.78% |
| Dec 31, 2024 | 152.14B | 17.95B | 13.38% |
| Dec 31, 2023 | 134.19B | 34.61B | 34.76% |
| Dec 31, 2022 | 99.58B | -6.08B | -5.75% |
| Dec 31, 2021 | 105.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 7.73T |
| PT Medikaloka Hermina Tbk | 7.37T |
| PT Famon Awal Bros Sedaya Tbk | 2.77T |
| PT Sarana Meditama Metropolitan Tbk | 2.03T |
| PT Bundamedik Tbk | 1.65T |
| PT Murni Sadar Tbk | 1.57T |
| PT Nitrasanata Dharma | 942.27B |
| PT Metro Healthcare Indonesia Tbk | 571.05B |